| Brigid R Marriott, PHD | |
|
1002 Wishard Blvd Ste 4110, Indianapolis, IN 46202-4164 | |
| (317) 944-8162 | |
| (317) 948-0609 |
| Full Name | Brigid R Marriott |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 1002 Wishard Blvd Ste 4110, Indianapolis, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013609809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 20043685A (Indiana) | Primary |
| Entity Name | Indiana University Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902032832 PECOS PAC ID: 5799755864 Enrollment ID: O20040727000955 |
News Archive
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.
Avesthagen Limited has yet again established its position as a leader in the successful application of next gen technologies as it announces the completion of the first Parsi breast cancer whole genome sequence of a 74-year-old Parsi woman with a heritable form of breast cancer. The incidence of breast cancer in most populations is strongly linked to a genetic basis but little is known about the variants at the present time.
Ashion Analytics, a clinical laboratory of the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is now part of the National Cancer Institute's MATCH program, which provides patients who have rare or difficult-to-treat cancers with access to unique clinical trials nationwide that might give them the best therapeutic treatments and outcomes.
Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Dr. Reddy presented the one-year LEADLESS study data findings during his late-breaking clinical trial presentation on May 9 at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco, CA.
New research from the University of California, Davis, and the University of Colorado at Boulder puts an unexpected twist on how mitochondria, the energy-generating structures within cells, divide.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brigid R Marriott, PHD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Brigid R Marriott, PHD 1002 Wishard Blvd Ste 4110, Indianapolis, IN 46202-4164 Ph: (317) 944-8162 |
News Archive
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.
Avesthagen Limited has yet again established its position as a leader in the successful application of next gen technologies as it announces the completion of the first Parsi breast cancer whole genome sequence of a 74-year-old Parsi woman with a heritable form of breast cancer. The incidence of breast cancer in most populations is strongly linked to a genetic basis but little is known about the variants at the present time.
Ashion Analytics, a clinical laboratory of the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is now part of the National Cancer Institute's MATCH program, which provides patients who have rare or difficult-to-treat cancers with access to unique clinical trials nationwide that might give them the best therapeutic treatments and outcomes.
Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Dr. Reddy presented the one-year LEADLESS study data findings during his late-breaking clinical trial presentation on May 9 at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco, CA.
New research from the University of California, Davis, and the University of Colorado at Boulder puts an unexpected twist on how mitochondria, the energy-generating structures within cells, divide.
› Verified 2 days ago
Dr. Jennifer Holzman, PSYD, HSPP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 70 E 91st St Ste 210, Indianapolis, IN 46240 Phone: 317-573-0149 | |
Dr. Sarah A Landsberger, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 355 W 16th St, Indianapolis, IN 46202 Phone: 317-963-7300 Fax: 317-963-7325 | |
Dr. William D. Alexy, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6110 N. Meridian, W.dr, Indianapolis, IN 46208 Phone: 317-255-3729 Fax: 317-255-3729 | |
Dr. Yelena Chernyak, PH.D., HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd, Room Uh 3240, Indianapolis, IN 46202 Phone: 317-944-7422 Fax: 317-944-1497 | |
Tami S Krichiver, PSYD, HSPP Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2011 N Meridian St, Indianapolis, IN 46202 Phone: 317-924-7010 Fax: 317-941-2208 | |
Dr. Lisa B Brown, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6284 Rucker Rd, Suite N, Indianapolis, IN 46220 Phone: 317-475-1389 Fax: 317-475-9089 |